Pacific Palisades, CA, United States of America

James Economou

This inventor holds 3 USPTO granted patents. Top assignees: University of California, California Institute of Technology. Active years: 2006-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Economou. Retrieved from https://idiyas.com/inventor/james-economou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2006-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of James Economou

Introduction

James Economou is a prominent inventor based in Pacific Palisades, California. He has made significant contributions to the field of immunology, particularly in the development of T-cell receptors for cancer treatment. With a total of 3 patents, Economou's work has the potential to impact the lives of many patients suffering from melanoma.

Latest Patents

One of Economou's latest patents includes the MART-1 T cell receptors. These T-cell receptors are designed to recognize the MART-1 antigen, which is crucial for targeting melanoma cells. The innovative TCRs can be utilized in therapeutic applications, offering hope for effective treatments for patients battling this aggressive form of skin cancer.

Career Highlights

Throughout his career, Economou has been associated with prestigious institutions such as the University of California and the California Institute of Technology. His work in these renowned organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

James Economou has collaborated with notable scientists, including Lili Yang and David Baltimore. These partnerships have fostered an environment of innovation and have led to groundbreaking advancements in the field of cancer immunotherapy.

Conclusion

James Economou's contributions to the development of T-cell receptors exemplify the impact of innovative research in medicine. His work not only enhances our understanding of cancer treatment but also paves the way for future advancements in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…